(Q50644397)

17 March 2018

title

Optimum number of oocytes for a successful first IVF treatment cycle. (English)

1 reference

17 March 2018

author name string

van der Gaast MH

1

1 reference

17 March 2018

Eijkemans MJ

2

1 reference

17 March 2018

van der Net JB

3

1 reference

17 March 2018

de Boer EJ

4

1 reference

17 March 2018

Burger CW

5

1 reference

17 March 2018

van Leeuwen FE

6

1 reference

17 March 2018

Fauser BC

7

1 reference

17 March 2018

Macklon NS

8

1 reference

17 March 2018

publication date

1 October 2006

1 reference

17 March 2018

Reproductive BioMedicine Online

published in

1 reference

17 March 2018

volume

13

1 reference

17 March 2018

issue

4

1 reference

17 March 2018

page(s)

476-480

1 reference

17 March 2018

Preimplantation genetic screening reveals a high incidence of aneuploidy and mosaicism in embryos from young women undergoing IVF

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960633-5

7 January 2021

The endometrium in stimulated cycles for IVF.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960633-5

7 January 2021

Reproductive biology and IVF: ovarian stimulation and endometrial receptivity

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960633-5

7 January 2021

Towards single births after assisted reproduction treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960633-5

7 January 2021

Time to revolutionize ovarian stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960633-5

7 January 2021

Multiple birth resulting from ovarian stimulation for subfertility treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960633-5

7 January 2021

Minimal ovarian stimulation for IVF: appraisal of potential benefits and drawbacks

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960633-5

7 January 2021

Pharmacogenetics in ovarian stimulation - current concepts and future options

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960633-5

7 January 2021

A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960633-5

7 January 2021

Risk of cancer in the offspring of women who underwent ovarian stimulation for IVF

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960633-5

7 January 2021

Hormonal regulation of implantation

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960633-5

7 January 2021

Regulation of follicle development and novel approaches to ovarian stimulation for IVF.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960633-5

7 January 2021

The science behind 25 years of ovarian stimulation for in vitro fertilization

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960633-5

7 January 2021

Chromosome abnormalities and their relationship to morphology and development of human embryos

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960633-5

7 January 2021

Supraphysiological estradiol levels do not affect oocyte and embryo quality in oocyte donation cycles

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960633-5

7 January 2021

A prospective randomized clinical trial comparing an individual dose of recombinant FSH based on predictive factors versus a 'standard' dose of 150 IU/day in 'standard' patients undergoing IVF/ICSI treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960633-5

7 January 2021

Factors influencing the cumulative conception rate and discontinuation of in vitro fertilization treatment for infertility.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960633-5

7 January 2021

Increasing uterine receptivity by decreasing estradiol levels during the preimplantation period in high responders with the use of a follicle-stimulating hormone step-down regimen.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960633-5

7 January 2021

Clinical evidence for a detrimental effect on uterine receptivity of high serum oestradiol concentrations in high and normal responder patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960633-5

7 January 2021

Clinical management of low ovarian response to stimulation for IVF: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960633-5

7 January 2021

Factors that affect outcome of in-vitro fertilisation treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960633-5

7 January 2021

Ovarian stimulation and endometrial receptivity

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960633-5

7 January 2021

Ovarian stimulation for IVF and endometrial receptivity--the missing link.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960633-5

7 January 2021

Egg production predicts a doubling of in vitro fertilization pregnancy rates even within defined age and ovarian reserve categories.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960633-5

7 January 2021

10.1016/S1472-6483(10)60633-5

Identifiers

DOI

1 reference

17 March 2018

1 reference

17 March 2018